Analysis of additional tumor-associated AXIN1 variants located at conserved residues within the C-terminal part of the Tankyrase domain for their ability to impact β-catenin signaling.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: